SCA
BIIB icon

SAC Capital Advisors’s Biogen BIIB Stock Holding History

SAC Capital Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-258,862
Closed -$79.2M – 141
2014
Q1 		$79.2M Sell
258,862
-2,043
-0.8% -$649K 0.41% 46
2013
Q4 		$73M Buy
260,905
+56,300
+28% +$14.6M 0.42% 56
2013
Q3 		$49.3M Sell
204,605
-249,466
-55% -$55.8M 0.27% 96
2013
Q2 		$97.7M Buy
+454,071
New +$97M 0.54% 29

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

SAC Capital Advisors's BIIB Position: Q2 2014 in Review

SAC Capital Advisors sold out of Biogen (BIIB) in Q2 2014, closing a stake of 258,862 shares — an estimated $79.2M sold.

SAC Capital Advisors first reported a position in BIIB in Q2 2013 and held it in 4 quarters. The position peaked at $97.7M in Q2 2013. 782 funds tracked by Wall St. Rank hold BIIB as of Q2 2014.

  • SAC Capital Advisors reported no remaining Biogen position as of Q2 2014 after selling out during the quarter.
  • SAC Capital Advisors sold 258,862 Biogen shares in Q2 2014, an estimated $79.2M.
  • SAC Capital Advisors first reported a position in Biogen in Q2 2013 and held it in 4 quarters.
  • SAC Capital Advisors's Biogen position peaked at $97.7M in Q2 2013.
  • 782 funds tracked by Wall St. Rank held Biogen as of Q2 2014.

Based on SAC Capital Advisors's 13F filing for Q2 2014.